ABT:NYE-Abbott Laboratories (USD)

COMMON STOCK | Medical Devices | NYE

Last Closing Price

USD 74.56

Change

-1.25 (-1.65)%

Market Cap

USD 131.48B

Volume

8.34M

Average Target Price

USD 97.69 (+31.03%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-03-27 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MDT Medtronic plc

-2.05 (-2.23%)

USD116.35B 21.65 12.89
SYK Stryker Corporation

-4.11 (-2.52%)

USD61.22B 29.80 15.45
EW Edwards Lifesciences Corporati..

-1.29 (-0.65%)

USD41.71B 40.45 29.40
BSX Boston Scientific Corporation

-0.81 (-2.58%)

USD39.40B 8.47 16.40
ZBH Zimmer Biomet Holdings, Inc

-5.91 (-5.86%)

USD16.68B 14.77 10.86
SNN Smith & Nephew plc

+0.66 (+1.91%)

USD14.42B 25.25 12.42
BIO-B Bio-Rad Laboratories, Inc

N/A

USD10.21B 5.70 24.47
BIO Bio-Rad Laboratories, Inc

-18.85 (-5.52%)

USD9.60B 5.53 25.19
PEN Penumbra, Inc

-3.71 (-2.33%)

USD5.58B 118.72 92.25
GMED Globus Medical, Inc

-1.52 (-3.53%)

USD4.04B 26.61 16.47

ETFs Containing ABT

Symbol Name Weight Mer Price(Change) Market Cap
IHI iShares U.S. Medical Devi.. 12.85 % 0.43 %

-4.05 (-1.81%)

USD4.59B
ZFN:CA BMO SIA Focused North Ame.. 6.60 % 0.80 %

-0.04 (-0.14%)

USD0.18B
ACT AdvisorShares Vice ETF 5.45 % 0.99 %

-0.55 (-2.86%)

USD0.01B
FHI-B:CA CI First Asset Health Car.. 5.18 % 0.81 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 4.95 % 0.56 %

-1.34 (-2.52%)

USD0.33B
PBE Invesco Dynamic Biotechno.. 4.95 % 0.57 %

-0.94 (-2.04%)

USD0.21B
ZPDH:F SPDR S&P U.S. Health Care.. 4.17 % 0.15 %

-0.32 (-1.44%)

USD0.18B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 4.17 % 0.15 %

-0.11 (-0.49%)

USD0.18B
SXLV:LSE SPDR S&P U.S. Health .. 4.17 % 0.15 %

-0.09 (-0.37%)

USD0.18B
QDVG:XETRA iShares S&P 500 Health Ca.. 4.16 % 0.15 %

-0.02 (-0.40%)

USD1.17B
IHCU:LSE iShares S&P 500 Healt.. 4.16 % 0.15 %

-13.13 (-2.51%)

USD1.17B
QDVG:F iShares S&P 500 Health Ca.. 4.16 % 0.15 %

-0.08 (-1.39%)

USD1.17B
IUHC:LSE iShares S&P 500 Healt.. 4.16 % 0.15 %

N/A

USD1.17B
XUHC:LSE Xtrackers MSCI USA Health.. 3.99 % 0.12 %

+0.07 (+0.19%)

USD0.40B
XSHC:LSE Xtrackers MSCI USA Health.. 3.99 % 0.12 %

-73.00 (-2.56%)

USD0.40B
XUHC:XETRA Xtrackers MSCI USA Health.. 3.99 % 0.12 %

-0.14 (-0.43%)

USD0.40B
XLV Health Care Select Sector.. 3.95 % 0.13 %

-1.86 (-2.14%)

USD18.51B
IYH iShares U.S. Healthcare E.. 3.61 % 0.43 %

-4.74 (-2.57%)

USD2.10B
VHT Vanguard Health Care Inde.. 3.53 % 0.10 %

-3.38 (-2.07%)

USD10.48B
GDNA Goldman Sachs Motif Human.. 3.35 % 0.50 %

-0.93 (-1.93%)

USD0.01B
FHLC Fidelity MSCI Health Care.. 3.33 % 0.08 %

-1.00 (-2.37%)

USD1.61B
XHC:CA iShares Global Healthcare.. 2.81 % 0.65 %

-1.15 (-2.45%)

USD0.29B
ISUS:LSE iShares MSCI USA Islamic .. 2.75 % 0.50 %

-115.00 (-3.80%)

USD0.08B
ISDU:LSE iShares MSCI USA Islamic .. 2.75 % 0.50 %

-0.57 (-1.56%)

USD0.08B
XDWH:F Xtrackers MSCI World Heal.. 2.72 % 0.30 %

-0.51 (-1.71%)

USD0.47B
XDWH:XETRA Xtrackers MSCI World Heal.. 2.72 % 0.30 %

-0.08 (-0.26%)

USD0.47B
XDWH:LSE Xtrackers MSCI World Heal.. 2.72 % 0.30 %

+0.57 (+1.78%)

USD0.47B
WHEA:LSE SPDR MSCI World Health Ca.. 2.69 % 0.30 %

-0.11 (-0.29%)

USD0.30B
IXJ iShares Global Healthcare.. 2.63 % 0.46 %

-0.98 (-1.65%)

USD2.01B
VIG Vanguard Dividend Appreci.. 2.60 % 0.06 %

-2.31 (-2.22%)

USD48.41B
JHMH John Hancock Multifactor .. 2.38 % 0.40 %

-0.74 (-2.31%)

USD0.04B
CURE Direxion Daily Healthcare.. 2.30 % 1.08 %

-2.51 (-6.62%)

USD0.12B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.33 (-1.74%)

USD6.32M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.85 (+4.34%)

USD2.76M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.85 (+4.34%)

USD2.76M
FDMO Fidelity Momentum Factor .. 0.00 % 0.29 %

-0.88 (-2.84%)

USD0.09B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-4.01 (-4.58%)

USD0.11B
SPMO Invesco S&P 500 Momentum .. 0.00 % 0.13 %

-0.89 (-2.44%)

USD0.06B
BSCL Invesco BulletShares 2021.. 0.00 % 0.10 %

+0.39 (+1.89%)

USD1.90B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.45 %

+0.67 (+3.77%)

USD0.01B
LIFE aTyr Pharma, Inc 0.00 % 0.00 %

+0.16 (+5.19%)

USD0.02B
FHI Federated Hermes, Inc 0.00 % 0.00 %

-0.76 (-4.02%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.16% 70% C- 74% C
Dividend Return 0.41% 75% C 21% F
Total Return -13.75% 70% C- 74% C
Trailing 12 Months  
Capital Gain -6.14% 67% D+ 76% C
Dividend Return 1.66% 67% D+ 41% F
Total Return -4.48% 67% D+ 75% C
Trailing 5 Years  
Capital Gain 59.38% 50% F 91% A-
Dividend Return 11.93% 86% B 46% F
Total Return 71.31% 57% F 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 18.20% 45% F 88% B+
Dividend Return 2.22% 100% A+ 50% F
Total Return 20.43% 45% F 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 18.52% 55% F 39% F
Risk Adjusted Return 110.33% 60% D- 86% B
Market Capitalization 131.48B 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.19 27% F 12% F
Price/Book Ratio 4.23 26% F 13% F
Price / Cash Flow Ratio 21.43 48% F 11% F
EV/EBITDA 18.82 30% F 12% F
Management Effectiveness  
Return on Equity 11.89% 65% D 66% D
Return on Invested Capital 9.11% 74% C 68% D+
Return on Assets 4.53% 68% D+ 72% C-
Debt to Equity Ratio 53.59% 56% F 59% F
Technical Ratios  
Short Ratio 2.63 43% F 39% F
Short Percent 1.34% 69% D+ 84% B
Beta 1.15 22% F 34% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.